Ferrostatin-1
SIGMA/SML0583 - ≥95% (HPLC)
Synonym: 3-
CAS Number: 347174-05-4
Empirical Formula (Hill Notation): C15H22N2O2
Molecular Weight: 262.35
Linear Formula: C15H22N2O2
Product Type: Chemical
| assay | ≥95% (HPLC) |
| color | , faint purple to brown |
| form | powder |
| InChI | 1S/C15H22N2O2/c1-2-19-15( |
| InChI key | UJHBVMHOBZBWMX-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | N(C2CCCCC2)c1c(cc(cc1)C(= |
| solubility | DMSO: 10 mg/mL, clear |
| storage temp. | 2-8°C |
| Application: | Ferrostatin-1 has been used to determine its inhibitory effect on the cell death profiles. |
| Biochem/physiol Actions: | Ferrostatin-1 is a potent inhibitor of non-apoptotic cell death induced by erastin call ferroptosis. |
| Biochem/physiol Actions: | Ferrostatin-1 is a potent inhibitor of non-apoptotic cell death induced by erastin call ferroptosis. Ferrostatin-1 prevents ferroptopic cell death in cancer cells and glutamate-induced toxicity in organotypic rat brain slices. It appears that Ferrostatin-1 controls lipid soluble ROS. |
| Biochem/physiol Actions: | Ferrostatin-1 is an active radical-trapping antioxidant that traps peroxyl radicals, and thus serves as a potential inhibitor of ferroptosis. Ferroptosis is considered as regulated necrosis, which differs from apoptosis and autophagy. Ferrostatin-1 is known to show protective effects against Huntington’s disease and also prevents neurotoxicity induced by glutamate in cellular models. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


